Symptom Monitoring App Use Associated With Medication Adherence Among Woman Survivors of Breast Cancer on Adjuvant Endocrine Therapy
Use of a remote monitoring app was similar across sociodemographic characteristics, and more frequent app use was associated with a higher likelihood of 6-month AET adherence. Encouraging women to monitor medication adherence and communicate adverse symptoms could improve AET adherence.
Authors
- Xin Hu (ORCID: https://orcid.org/0000-0003-1097-3300)
- Ilana Graetz (ORCID: https://orcid.org/0000-0003-3664-5815)
- Janeane N. Anderson (ORCID: https://orcid.org/0000-0003-2602-6957)
- Lee S. Schwartzberg (ORCID: https://orcid.org/0000-0002-7433-3428)
- Gregory A. Vidal (ORCID: https://orcid.org/0000-0003-3325-6224)
- Rebecca A. Krukowski (ORCID: https://orcid.org/0000-0001-9193-2783)
- Edward Stepanski (ORCID: https://orcid.org/0000-0003-3167-2347)
- Sara Arshad (ORCID: https://orcid.org/0009-0009-0754-3159)
Institutions
- University of Nevada, Reno (US)
- Emory University (US)
- University of Tennessee Health Science Center (US)
- Renown Health (US)
- West Cancer Center (US)
- Ovation Fertility (US)
- University of Virginia Cancer Center
- University of Virginia (US)
Publication Details
- Journal
- JCO Clinical Cancer Informatics
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1200/cci-24-00179
- Citations
- 4
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Pharmaceutical Research and Manufacturers of America Foundation
- Pfizer
- St. Jude Children's Research Hospital
- National Institutes of Health
- National Cancer Institute